Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19 Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05057923
What this trial is testing

The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores

Who this might be right for
COVID-19 Pneumonia
DreamTec Research Limited 9
Not applicableStudy completedNCT05858450
What this trial is testing

This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.

Who this might be right for
Influenza, HumanCOVID-19
Pfizer 3,442,996
Testing effectiveness (Phase 2)Study completedNCT04821674
What this trial is testing

Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects

Who this might be right for
Covid19
Daiichi Sankyo Co., Ltd. 142
Not applicableWithdrawnNCT06505993
What this trial is testing

Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia

Who this might be right for
COVID-19Vaccine Hesitancy
Marc Kiviniemi
Not applicableStudy completedNCT07610512
What this trial is testing

Immunomodulatory Effect of Probiotics on the Immunogenicity of Anti-SARS-CoV-2 Vaccines

Who this might be right for
COVID-19Immune Response
Grape King Bio Ltd. 138
Not applicableStudy completedNCT05049187
What this trial is testing

Characterization and Durability of COVID-19 Vaccine Induced Immune Responses in Healthcare/Frontline Workers

Who this might be right for
Covid19
Tuberculosis Research Centre, India 132
Large-scale testing (Phase 3)Ended earlyNCT04642638
What this trial is testing

Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure

Who this might be right for
Coronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)COVID-19 Disease
Inovio Pharmaceuticals 1,307
Not applicableUnknownNCT05094635
What this trial is testing

Immunogenicity Against SARS-CoV-2 in COVID-19 Close Contacts

Who this might be right for
Covid19Vaccine Reaction
University of Medicine and Pharmacy at Ho Chi Minh City 772
Large-scale testing (Phase 3)Ended earlyNCT05169008
What this trial is testing

Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents

Who this might be right for
COVID-19
CanSino Biologics Inc. 91
Testing effectiveness (Phase 2)WithdrawnNCT04386252
What this trial is testing

Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults

Who this might be right for
COVID-19
Aivita Biomedical, Inc.
Not applicableActive Not RecruitingNCT06333704
What this trial is testing

Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGE

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 4,207
Not applicableStudy completedNCT05031468
What this trial is testing

Multisite Observational Maternal and Infant Study for COVID-19

Who this might be right for
COVID-19
Emory University 562
Large-scale testing (Phase 3)UnknownNCT05686161
What this trial is testing

MRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs

Who this might be right for
ImmunogenicitySafetyEfficacy
Stemirna Therapeutics 600
Post-approval studies (Phase 4)UnknownNCT05097053
What this trial is testing

A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19

Who this might be right for
COVID-19 Vaccine
Taoyuan General Hospital 200
Large-scale testing (Phase 3)Study completedNCT05188677
What this trial is testing

Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults

Who this might be right for
COVID-19
Clover Biopharmaceuticals AUS Pty 1,831
Not applicableUnknownNCT04733807
What this trial is testing

Antibodies Response to mRNA Vaccine Against Covid-19

Who this might be right for
Covid-19
University of Roma La Sapienza 600
Early research (Phase 1)Study completedNCT05272605
What this trial is testing

Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults

Who this might be right for
SARS-CoV-2
University of Melbourne 76
Testing effectiveness (Phase 2)Study completedNCT05289037
What this trial is testing

COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 1,270
Early research (Phase 1)Study completedNCT04818281
What this trial is testing

Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults

Who this might be right for
Covid19
Ihsan GURSEL, PhD, Prof. 38
Post-approval studies (Phase 4)Study completedNCT04505774
What this trial is testing

Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE

Who this might be right for
Covid19
Matthew Neal MD 3,591
Next Page